A lower cost alternative to an oral medication used to treat multiple sclerosis has launched in the U.S. market by a Mahwah-base…

A lower cost alternative to an oral medication used to treat multiple sclerosis has launched in the U.S. market by a Mahwah-based firm. https://trib.al/gNr5tXi

SOURCE